Evidence map›Paper›PMID 27346971›Full record

ArticleBiochemia medica2016

Interference of M-protein on prothrombin time test - case report.

Sandra Margetić, Ivana Ćelap, Lora Dukić, Ines Vukasović, Lucija Virović-Jukić

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Biochemia medica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Multiple myeloma and primary erythrocytosis in a dog.The Canadian veterinary journal = La revue veterinaire canadienne · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sandra MargetićClinical Institute of Chemistry, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
Ivana ĆelapClinical Institute of Chemistry, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
Lora DukićClinical Institute of Chemistry, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
Ines VukasovićClinical Institute of Chemistry, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
Lucija Virović-JukićUniversity Department of Internal Medicine, Medical School University Hospital Sestre milosrdnice, Zagreb, Croatia.
Sisters of Charity Hospital · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this report was to present a case of interference on prothrombin time (PT) test that directed further laboratory diagnostics and resulted with final detection of monoclonal gammopathy in an 88-year old man. Routine coagulation testing during medical examination at Emergency Department revealed unmeasurable PT (< 7% activity) and activated partial thromboplastin time (aPTT) within reference range. After repeated sampling for coagulation testing, PT was unmeasurable again, as well as fibrinogen level (< 0.8 g/L), thrombin time (TT) was significantly prolonged (107 seconds) and aPTT was within reference range. In both plasma samples refrigerated at 4 ˚C overnight, white gelatinous precipitate was visible between the cell and plasma layers and the presence of monoclonal protein (M-protein) was suggested in our patient. Further laboratory diagnostics revealed total serum proteins at concentration of 123 g/L and the presence of M-protein IgG lambda (λ) at concentration of 47.1 g/L. These results suggested monoclonal gammopathy as an underlying pathophysiological condition in our patient. Activities of coagulation factors II, V, VII and X were within reference ranges or increased. These results and correction of unmeasurable PT result to 67% in mixing test with commercial normal plasma suggest in vitro rather than in vivo interference of M-protein on PT result. In contrast, significantly prolonged TT results in all analysed samples suggest impact of M-protein on this global coagulation test due to possible effect on fibrin polymerization.

Indexed as

Aged, 80 and overBlood CoagulationConnectinHumansMaleParaproteinemiasProthrombinProthrombin TimeConnectinProthrombininterferencemonoclonal gammopathyM-proteinprothrombin timethrombin time

Identifiers

PMID27346971
PMCPMC4910265
OpenAlexW2412080085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.